First Horizon Advisors Inc. bought a new position in shares of iShares MSCI Intl Value Factor ETF (NYSEARCA:IVLU – Free ...

Sigma Planning Corp boosted its position in shares of FT Cboe Vest U.S. Equity Moderate Buffer ETF – May (NYSEARCA:GMAY – ...

Gold prices (XAUUSD:CUR) fell over 1% on Thursday, set for a third-consecutive session of losses, as the U.S. dollar (DXY) ...

Highlights,Principal Securities Inc. increased its investment in ISCB by 187.5% in the fourth quarter, acquiring 780 additional shares.,Several other hedge funds and institutional investors updated ...

NYSE Arca has filed a 19b-4 form for Grayscale's $ADA ETF, triggering a price pump on the Cardano coin that outperformed Bitcoin and all other altcoins on the Top 10 list of cryptocurrencies with the ...

The SEC reviews Grayscale Ethereum ETF's staking proposal, with a decision expected by May 26, potentially impacting staking ...

The NYSE Arca filing details how the SEC could allow Grayscale's Ethereum funds to earn staking rewards while maintaining ...

Highlights,Principal Securities Inc. increased its position in Vanguard S&P 500 Growth ETF by 13.5% in the fourth quarter, ...

So, someone making more than $1 million annually is “really killing it,” according to New York University professor Scott ...

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Cardano (ADA) is among the front runners for crypto ETF approval in 2025, along with Litecoin, XRP and Solana.

NYSE Arca, a subsidiary of the NYSE Group, has filed on behalf of crypto asset manager Grayscale to launch a spot Cardano exchange-traded fund (ETF). In a Feb. 10 proposed rule change filing to the ...